Primary Care Corner with Geoffrey Modest MD: Low use of buprenorphine in youth

by Dr Geoffrey Modest A recent large-scale analysis from health insurance claims found that under one-quarter of adolescents and young adults with opioid use disorder (OUD) received either buprenorphine or naltrexone (see┬ádoi:10.1001/jamapediatrics.2017.0745)   Details: — retrospective cohort study based on reviewed insurance claims of 9.7 million youth aged 13 to 25; they identified 20,822 with […]

Read More…